Botanix Pharmaceuticals Ltd Asset Resilience Ratio

Latest as of June 1996: 6.42%

Botanix Pharmaceuticals Ltd asset resilience ratio. Botanix Pharmaceuticals Ltd (BOT) has an Asset Resilience Ratio of 6.42% as of June 1996. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See defensive interval ratio of Botanix Pharmaceuticals Ltd to measure how many days the company can operate on defensive assets alone.

Liquid Assets

AU$3.66 Million

≈ $2.59 Million USD Cash + Short-term Investments

Total Assets

AU$57.05 Million

≈ $40.36 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Botanix Pharmaceuticals Ltd (1992–2019)

Asset resilience ratio of Botanix Pharmaceuticals Ltd from 1992 to 2019. This chart shows how Botanix Pharmaceuticals Ltd's Asset Resilience Ratio has changed over time. Read Botanix Pharmaceuticals Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Botanix Pharmaceuticals Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Botanix Pharmaceuticals Ltd balance sheet assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$0.00	0%
Short-term Investments	AU$3.66 Million	6.42%
Total Liquid Assets	AU$3.66 Million	6.42%

Asset Resilience Insights

Limited Liquidity: Botanix Pharmaceuticals Ltd maintains only 6.42% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Botanix Pharmaceuticals Ltd Industry Peers by Asset Resilience Ratio

Compare Botanix Pharmaceuticals Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Samsung Biologics Co Ltd KO:207940	Biotechnology	15.21%
Abivax SA PA:ABVX	Biotechnology	2.58%
Tubize-Fin BR:TUB	Biotechnology	2.50%
BB Biotech AG SW:BION	Biotechnology	92.97%
Sinocelltech Group Ltd SHG:688520	Biotechnology	5.27%
Inner Mongolia Furui Med Sci SHE:300049	Biotechnology	1.75%
Mineralys Therapeutics, Inc. Common Stock NASDAQ:MLYS	Biotechnology	78.33%
GH Research PLC NASDAQ:GHRS	Biotechnology	4.73%

Botanix Pharmaceuticals Ltd Asset Resilience Ratio by Year (1992–2019)

Botanix Pharmaceuticals Ltd asset resilience ratio by year from 1992 to 2019. The table below shows the annual Asset Resilience Ratio data for Botanix Pharmaceuticals Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2019-06-30	0.00%	AU$0.00 ≈ $0.00	AU$5.20 Million ≈ $3.68 Million	--
2018-06-30	0.12%	AU$20.44K ≈ $14.46K	AU$17.71 Million ≈ $12.53 Million	--
2017-06-30	0.00%	AU$0.00 ≈ $0.00	AU$5.91 Million ≈ $4.18 Million	--
2016-06-30	0.00%	AU$0.00 ≈ $0.00	AU$3.70 Million ≈ $2.62 Million	--
1996-06-30	6.42%	AU$3.66 Million ≈ $2.59 Million	AU$57.05 Million ≈ $40.36 Million	+3.42pp
1995-06-30	3.00%	AU$2.04 Million ≈ $1.45 Million	AU$68.16 Million ≈ $48.23 Million	-0.61pp
1994-06-30	3.61%	AU$1.75 Million ≈ $1.24 Million	AU$48.56 Million ≈ $34.36 Million	+0.27pp
1993-06-30	3.34%	AU$1.27 Million ≈ $897.90K	AU$38.03 Million ≈ $26.91 Million	-2.04pp
1992-06-30	5.38%	AU$1.40 Million ≈ $987.05K	AU$25.92 Million ≈ $18.34 Million	--

pp = percentage points

About Botanix Pharmaceuticals Ltd

AU:BOT Australia Biotechnology

Market Cap

$15.34 Million

AU$21.68 Million AUD

Market Cap Rank

#25747 Global

#1120 in Australia

Share Price

AU$0.01

Change (1 day)

+22.22%

52-Week Range

AU$0.01 - AU$0.14

All Time High

AU$0.52